In addition to affecting the tumour cells directly, LPI derived from ovarian cancer cells and ovarian cancer cell lines cause endothelial cell proliferation through binding to GPR55 causing activation of ERK1/2 and p38 (Hofmann et al. 2015). Here, MAPK3 is linked to ovarian carcinoma.